共 50 条
- [2] Clostridium difficile Infection in Patients With Ulcerative Colitis Treated With Tofacitinib in the Ulcerative Colitis Program: An Update as of May 2019 [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S333 - S334
- [3] Clostridium difficile infection in ulcerative colitis: Data from the tofacitinib clinical program and an insurance claims database [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S10 - S10
- [4] Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S427 - S429
- [6] Impact of Clostridium difficile infection in patients with ulcerative colitis [J]. JOURNAL OF CROHNS & COLITIS, 2011, 5 (01): : 34 - 40
- [7] Tofacitinib for the Treatment of Ulcerative Colitis: An Updated Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S323 - S323
- [8] Clostridium difficile infection in ulcerative colitis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S261 - S261
- [9] Analysis of Infections of Interest in Patients Treated with Tofacitinib in the Ulcerative Colitis Clinical Program [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S406 - S406
- [10] Incidence of Venous Thromboembolic Events in Patients With Ulcerative Colitis Treated With Tofacitinib in the Ulcerative Colitis Clinical Development Program [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S377 - S377